Original language | English |
---|---|
Pages (from-to) | 415-417 |
Number of pages | 3 |
Journal | Bone Marrow Transplantation |
Volume | 60 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2025 |
Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party
J. Brijs*, C. Peczynski, W. Boreland, A. Cuoghi, J. Maertens, M. Mohty, N. Kröger, P. Nakov, A. E.C. Broers, M. Eder, C. Herrera Arroyo, M. Kaufmann, R. Ram, N. P.M. Schaap, C. Graham, A. Mussetti, O. Penack, I. Moiseev, Z. Peric, H. Schoemans
*Corresponding author for this work
- University Hospitals Leuven
- Hôpital Saint-Antoine
- EBMT Transplant Complications Working Party (TCWP)
- Azienda Ospedaliero - Universitaria di Modena Policlinico
- Immunology and Transplantation
- Universitatsklinikum Hamburg-Eppendorf und Medizinische Fakultat
- University Hospital Schleswig-Holstein
- Erasmus MC Cancer Institute
- Medizinische Hochschule Hannover (MHH)
- Reina Sofia Hosp, Hospital Universitario Reina Sofia, Liver Transplantat Unit
- Robert-Bosch- Krankenhaus
- Tel Aviv University
- Department of Neurology
- King's College London
- Hospital Duran i Reynals
- Institute for Radiology, CCM
- Saint Petersburg State University
- University Hospital Center Rijeka
- KU Leuven
Research output: Contribution to journal › Letter › peer-review
1
Citation
(Scopus)